SiBionics announced today that it received CE mark approval in Europe for its GS1 continuous glucose monitoring (CGM) system.
The company designed its CGM system to provide healthcare providers and patients with data necessary for maintaining glucose control. It offers 14 days of calibration-free continuous glucose monitoring and can transmit data to monitoring devices or mobile applications.
GS1 not only supports data sharing with friends and family but integrates the ProView remote access platform. ProView allows healthcare providers to remotely monitor and provide timely medical interventions.
Get the full story at our sister site, Drug Delivery Business News.